Differential efficacy of Osimertinib in EGFR T790M positive non-small cell lung cancer by metastatic site

被引：0
|
作者：
Uematsu, Shinya [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Div Thorac Med Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz338.080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO2 - 16 -
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [21] Osimertinib (AZD9291) increases radio-sensitivity in EGFR T790M non-small cell lung cancer
    Wang, Nannan
    Wang, Linlin
    Meng, Xiangjiao
    Wang, Jia
    Zhu, Lifang
    Liu, Changting
    Li, Shaorong
    Zheng, Li
    Yang, Zhenfan
    Xing, Ligang
    Yu, Jinming
    ONCOLOGY REPORTS, 2019, 41 (01) : 77 - 86
  • [22] Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients
    Alexeyenko, Andrey
    Brustugun, Odd Terje
    Eide, Inger Johanne Zwicky
    Gencheva, Radosveta
    Kosibaty, Zeinab
    Lai, Yi
    de Petris, Luigi
    Tsakonas, Georgios
    Grundberg, Oscar
    Franzen, Bo
    Viktorsson, Kristina
    Lewensohn, Rolf
    Hydbring, Per
    Ekman, Simon
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (10) : 2064 - +
  • [23] Multi-Site Audit of EGFR T790M Confirmation by Liquid/Tissue Biopsies and Osimertinib Use in Patients with EGFR Mutant Non-Small Cell Lung Cancer
    Davis, O. D.
    Al-Abdullah, A. A.
    Patterson, D. P.
    Doherty, G. J. D.
    Martin, A. M.
    JOURNAL OF PATHOLOGY, 2020, 250 : 7 - 7
  • [24] Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer
    Lin, Yi-Tsz
    Chu, Chia-Yu
    LUNG CANCER, 2019, 129 : 110 - 111
  • [25] Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
    John, Thomas
    Bowden, Jeffrey J.
    Clarke, Stephen
    Fox, Stephen B.
    Garrett, Kerryn
    Horwood, Keith
    Karapetis, Christos S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 296 - 303
  • [26] Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer
    Kotake, M.
    Murakami, H.
    Naito, T.
    Takahashi, T.
    Kenmotsu, H.
    Ono, A.
    Wakuda, K.
    Nakashima, K.
    Omori, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
    Lamb, Yvette N.
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2017, 12 (04) : 555 - 562
  • [28] Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
    Yvette N. Lamb
    Lesley J. Scott
    Targeted Oncology, 2017, 12 : 555 - 562
  • [29] Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
    Choo, Joan Rou-En
    Tan, Chee-Seng
    Soo, Ross A.
    TARGETED ONCOLOGY, 2018, 13 (02) : 141 - 156
  • [30] Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
    Joan Rou-En Choo
    Chee-Seng Tan
    Ross A. Soo
    Targeted Oncology, 2018, 13 : 141 - 156
12345